Drug Guide
Cefotetan Disodium
Classification
Therapeutic: Antibiotic, cephalosporin
Pharmacological: Second-generation cephalosporin
FDA Approved Indications
- Bacterial infections caused by susceptible organisms, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, gynecological infections, intra-abdominal infections
Mechanism of Action
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death.
Dosage and Administration
Adult: Dose varies depending on infection severity; typically 1-2 g every 12 hours IV or IM.
Pediatric: Dose based on weight and severity, usually 50-100 mg/kg/day divided every 12 hours.
Geriatric: Adjustments based on renal function; consider lower doses due to renal impairment.
Renal Impairment: Reduce dose or frequency according to creatinine clearance.
Hepatic Impairment: No specific adjustment required.
Pharmacokinetics
Absorption: Not absorbed from gastrointestinal tract (administered IV/IM).
Distribution: Widely distributed in body tissues and fluids.
Metabolism: Minimal hepatic metabolism.
Excretion: Primarily renal (urine).
Half Life: Approximately 1-2 hours.
Contraindications
- Hypersensitivity to cephalosporins or beta-lactam antibiotics.
Precautions
- Use with caution in patients with a history of allergy to penicillins, including potential cross-reactivity.
- Monitor for signs of hypersensitivity or allergic reactions.
Adverse Reactions - Common
- Diarrhea (Common)
- Vaginal moniliasis (yeast infection) (Less common)
Adverse Reactions - Serious
- Allergic reactions including anaphylaxis (Rare)
- Severe Clostridioides difficile-associated diarrhea (Reported but rare)
Drug-Drug Interactions
- Probenecid may increase cefotetan levels.
- Prolonged bleeding time may occur with anticoagulants.
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Assess for allergy to penicillins or other cephalosporins. Monitor for signs of hypersensitivity.
Diagnoses:
- Risk for allergic reaction
- Potential for superinfection.
Implementation: Administer IV/IM as prescribed. Monitor renal function and signs of superinfection.
Evaluation: Observe for resolution of infection, monitor for adverse reactions.
Patient/Family Teaching
- Report any signs of allergic reaction immediately.
- Complete the full course of therapy.
- Watch for and report persistent diarrhea or vaginal yeast infection.
Special Considerations
Black Box Warnings:
- None specifically for cefotetan, but be cautious of allergic reactions.
Genetic Factors: No well-known pharmacogenetic considerations.
Lab Test Interference: Cefotetan may interfere with coagulation tests; monitor PT/INR as needed.
Overdose Management
Signs/Symptoms: Potential for allergic reactions, diarrhea, gastrointestinal upset.
Treatment: Supportive care, monitor vital signs, and address allergic reactions. Hemodialysis may be considered in severe cases.
Storage and Handling
Storage: Store vials and containers at controlled room temperature (20-25°C).
Stability: Stable for the duration of the expiration date when stored properly.